First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer GroupMarinde J. G. Bond, Johanneke H.M.J.V. Vestjens, Miriam Koopman et al.|The Lancet Oncology|2023Cited by 168
Preperitoneal or Subcutaneous Wound Catheters as Alternative for Epidural Analgesia in Abdominal SurgeryTimothy H. Mungroop, Marc G. Besselink, Marinde J. G. Bond et al.|Annals of Surgery|2018Cited by 69
A review of the sensitivity of metastatic colorectal cancer patients with deficient mismatch repair to standard-of-care chemotherapy and monoclonal antibodies, with recommendations for future researchG. Emerens Wensink, Jeanine M.L. Roodhart, Marinde J. G. Bond et al.|Cancer Treatment Reviews|2021Cited by 38
First-Line Systemic Treatment for Initially Unresectable Colorectal Liver MetastasesMarinde J. G. Bond, Leonie J. Mekenkamp, Karen Bolhuis et al.|JAMA Oncology|2024Cited by 26
Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases: Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer GroupMarinde J. G. Bond, Rutger‐Jan Swijnenburg, Babette I Kuiper et al.|Annals of Surgical Oncology|2023Cited by 17